Journal article
What outcomes are important to patients with mild cognitive impairment or Alzheimer’s disease, their caregivers, and health-care professionals? A systematic review
- Abstract:
-
Introduction: Clinical trials involving patients with Alzheimer’s disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of the disease most relevant to key stakeholders.
Methods: A systematic review sought research that elicited information from people with AD, their caregivers, and health-care professionals on which outcomes of the disease were important. Studies published in any language between 2008 and 2017 were included.
Results: Participants in 34 studies described 32 outcomes of AD. These included clinical (memory, mental health), practical (ability to undertake activities of daily living, access to health information), and personal (desire for patient autonomy, maintenance of identity) outcomes of the disease.
Discussion: Evidence elicited directly from the people most affected by AD reveals a range of disease outcomes that are relevant to them but are not commonly captured in clinical trials of new treatments.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, 897.2KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.dadm.2018.12.003
Authors
- Publisher:
- Elsevier
- Journal:
- Alzheimer's and Dementia: Diagnosis, Assessment & Disease Monitoring More from this journal
- Volume:
- 11
- Issue:
- 2019
- Pages:
- 231-247
- Publication date:
- 2019-01-09
- Acceptance date:
- 2019-01-09
- DOI:
- EISSN:
-
2352-8729
- Pmid:
-
30906845
- Language:
-
English
- Keywords:
- Pubs id:
-
981573
- Local pid:
-
pubs:981573
- Deposit date:
-
2020-02-13
Terms of use
- Copyright holder:
- Tochel et al.
- Copyright date:
- 2018
- Rights statement:
- © 2018 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license
- Licence:
- CC Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)
If you are the owner of this record, you can report an update to it here: Report update to this record